Cormorant Asset Management, LP Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$1.6T
Holdings
71
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (71 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 2,350,000 | $183.1B | 11.14% | Put |
| 2 | —TURNING POINT THERAPEUTICS I | 3,541,367 | $133.2B | 8.11% | |
| 3 | SPYSPDR S&P 500 ETF TR | 400,000 | $118.7B | 7.23% | Put |
| 4 | —BIOHAVEN PHARMACTL HLDG CO L | 1,881,400 | $78.5B | 4.78% | Call |
| 5 | APLSAPELLIS PHARMACEUTICALS INC | 2,976,000 | $71.7B | 4.36% | |
| 6 | ASNDASCENDIS PHARMA A S | 718,300 | $69.2B | 4.21% | Call |
| 7 | RETAEURREATA PHARMACEUTICALS INC | 819,769 | $65.8B | 4.01% | |
| 8 | BBIOBRIDGEBIO PHARMA INC | 2,617,566 | $56.2B | 3.42% | |
| 9 | CRSPCRISPR THERAPEUTICS AG | 1,084,300 | $44.4B | 2.71% | |
| 10 | STOKSTOKE THERAPEUTICS INC | 1,788,394 | $38.4B | 2.34% | |
| 11 | —PRINCIPIA BIOPHARMA INC | 1,341,896 | $37.9B | 2.31% | |
| 12 | 2L9BLUEPRINT MEDICINES CORP | 493,000 | $36.2B | 2.20% | |
| 13 | QUREUNIQURE NV | 900,000 | $35.4B | 2.16% | |
| 14 | ALLKGUSDALLAKOS INC | 444,100 | $34.9B | 2.13% | |
| 15 | 1T7TRICIDA INC | 1,082,880 | $33.4B | 2.03% | |
| 16 | AXNX*AXONICS MODULATION TECH INC | 1,222,671 | $32.9B | 2.00% | |
| 17 | XBISPDR SERIES TRUST | 400,000 | $30.5B | 1.86% | Put |
| 18 | —QUOTIENT LTD | 3,642,000 | $28.3B | 1.72% | |
| 19 | NXTCNEXTCURE INC | 884,600 | $27.3B | 1.66% | |
| 20 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 788,500 | $26.8B | 1.63% | |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 2,123,760 | $24.7B | 1.51% | |
| 22 | —MYOKARDIA INC | 443,000 | $23.1B | 1.41% | |
| 23 | YMABUSDY-MABS THERAPEUTICS INC | 883,800 | $23.0B | 1.40% | |
| 24 | GLPGGALAPAGOS NV | 150,000 | $22.9B | 1.39% | |
| 25 | ANABANAPTYSBIO INC | 591,200 | $20.7B | 1.26% | |
| 26 | AMRNAMARIN CORP PLC | 1,332,000 | $20.2B | 1.23% | |
| 27 | —EIDOS THERAPEUTICS INC | 540,686 | $19.4B | 1.18% | |
| 28 | KURAKURA ONCOLOGY INC | 1,231,500 | $18.7B | 1.14% | |
| 29 | AKROAKERO THERAPEUTICS INC | 740,621 | $16.8B | 1.03% | |
| 30 | SRPTSAREPTA THERAPEUTICS INC | 221,700 | $16.7B | 1.02% | |
| 31 | TWSTTWIST BIOSCIENCE CORP | 687,149 | $16.4B | 1.00% | |
| 32 | ARGXARGENX SE | 128,110 | $14.6B | 0.89% | |
| 33 | NKTREURNEKTAR THERAPEUTICS | 788,800 | $14.4B | 0.87% | |
| 34 | —SATSUMA PHARMACEUTICALS INC | 858,382 | $12.9B | 0.78% | |
| 35 | SG7SAGE THERAPEUTICS INC | 88,700 | $12.4B | 0.76% | |
| 36 | CCXIEURCHEMOCENTRYX INC | 1,820,000 | $12.3B | 0.75% | |
| 37 | —HEALTH SCIENCES ACQUISITN CORP | 1,080,000 | $11.6B | 0.71% | |
| 38 | ASNSUSDX4 PHARMACEUTICALS INC | 881,681 | $11.2B | 0.68% | |
| 39 | INSPINSPIRE MED SYS INC | 172,300 | $10.5B | 0.64% | |
| 40 | GOSSGOSSAMER BIO INC | 618,129 | $10.4B | 0.63% | |
| 41 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 997,892 | $10.2B | 0.62% | |
| 42 | ZLABZAI LAB LTD | 277,161 | $9.0B | 0.55% | |
| 43 | —HARPOON THERAPEUTICS INC | 649,994 | $8.9B | 0.54% | |
| 44 | —AVROBIO INC | 568,294 | $8.0B | 0.49% | |
| 45 | ORTXUSDORCHARD THERAPEUTICS PLC | 675,325 | $8.0B | 0.49% | |
| 46 | ARNAEURARENA PHARMACEUTICALS INC | 172,300 | $7.9B | 0.48% | |
| 47 | —CONSTELLATION PHARMACEUTICAL I | 1,213,274 | $7.8B | 0.48% | |
| 48 | —RA PHARMACEUTICALS INC | 295,600 | $7.0B | 0.43% | |
| 49 | AUTLAUTOLUS THERAPEUTICS PLC | 479,988 | $6.0B | 0.36% | |
| 50 | GNFTYGENFIT S A | 300,000 | $5.2B | 0.32% | |
| 51 | BCELATRECA INC | 406,142 | $5.0B | 0.30% | |
| 52 | NERVGBPMINERVA NEUROSCIENCES INC | 607,903 | $4.7B | 0.29% | |
| 53 | FIXXEURHOMOLOGY MEDICINES INC | 245,100 | $4.4B | 0.27% | |
| 54 | ATRAGBXATARA BIOTHERAPEUTICS INC | 300,000 | $4.2B | 0.26% | |
| 55 | DTILPRECISION BIOSCIENCES INC | 467,518 | $3.9B | 0.24% | |
| 56 | RUBYUSDRUBIUS THERAPEUTICS INC | 491,700 | $3.9B | 0.23% | |
| 57 | NBIXNEUROCRINE BIOSCIENCES INC | 39,300 | $3.5B | 0.22% | |
| 58 | —PHASEBIO PHARMACEUTICALS INC | 816,448 | $3.4B | 0.21% | |
| 59 | KZRKEZAR LIFE SCIENCES INC | 927,869 | $3.0B | 0.19% | |
| 60 | 1K0IGM BIOSCIENCES INC | 156,400 | $2.8B | 0.17% | |
| 61 | ITRMITERUM THERAPEUTICS PLC | 396,385 | $2.3B | 0.14% | |
| 62 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 300,000 | $1.6B | 0.10% | Call |
| 63 | —AUDENTES THERAPEUTICS INC | 50,000 | $1.4B | 0.09% | |
| 64 | SRRKSCHOLAR ROCK HLDG CORP | 118,950 | $1.1B | 0.06% | |
| 65 | GTHXEURG1 THERAPEUTICS INC | 1,000 | $1.0B | 0.06% | |
| 66 | XLRNACCELERON PHARMA INC | 25,000 | $988.0M | 0.06% | |
| 67 | IFRXINFLARX NV | 300,000 | $741.0M | 0.05% | |
| 68 | —ABEONA THERAPEUTICS INC | 200,000 | $452.0M | 0.03% | |
| 69 | ACRSACLARIS THERAPEUTICS INC | 250,000 | $270.0M | 0.02% | |
| 70 | —OUTLOOK THERAPEUTICS INC | 416,666 | $50.0M | 0.00% | |
| 71 | ONSGBPOUTLOOK THERAPEUTICS INC | 15,753 | $23.0M | 0.00% |